Offisiell leverandør av medisinske produkter i Norge


Map of the averaged daily UV irradiation (in J/cm2) in Europe for the month of July averaged over the period 2003-2007.

This website has been created as part of the EuroSun project. The aim of this website is to make available all information concerning EuroSun, its methodology and results, to epidemiologists, community health authorities, national and international skin cancer prevention organisations and health professionals, researchers, and the general public. Viagra Norge: How long do the noticeable effects last?

The EuroSun project, titled “Quantification of sun exposure in Europe and its effects on health” is funded by the EU through the Public Health Executive Agency, grant n.2006320.

EuroSun is a large-scale, multidisciplinary, multiannual project, concerning all countries of the European Union, applicant countries, EEA countries, plus Switzerland. The associated partners have gathered and calculated UV irradiation data and tumour incidence and mortality by country for all locations. Les videre for å oppdage mer om typer kvinnelig Viagra: hvordan man kan kurere kvinnelig seksuell dysfunksjon.

Initiated in 2007 by Professor Peter Boyle, this project is henceforth coordinated by Dr. Mathieu Boniol, Research Director at the International Prevention Research Institute (iPRI). EuroSun also involves the following institutes: INSERM, France (Dr. Jean François Doré); ARMINES, France (Prof. Lucien Wald); and Karolinska Institutet, Sweden (Prof. Ulrik Ringborg).

Map of the averaged daily of UV irradiation in Europe for the month of July averaged over the period 2003-2007.
Map of the averaged daily UV irradiation (in J/cm2) in Europe for the month of July averaged over the period 2003-2007.

Public Health

This section describes public health outcomes of Eurosun project.

As with the pattern of holidays, the time spent outdoors varies significantly from one country to another; hence, any primary prevention message developed to reduce UV exposure has to be adapted for each country. We provide the following recommendations:

–      Usual prevention messages developed in Europe are often limited to exposure at the beach. Our results show that a high proportion of exposure, in particular in  central European countries (Estonia and Hungary), occurs in places not targeted by prevention messages. This type of exposure may occur in private and public recreational areas (gardens and parks), and in occupational settings. For those countries with populations experiencing few periods of holiday, prevention messages should focus on this type of exposure.

–      In northern European countries, such as Norway and Estonia, where the time spent outdoors at the place of residence is relatively high, prevention messages should also target the exposures described previously. This is especially important as our atlas of UV irradiation showed that in spring and early summer, when such exposure results from behaviours including gardening and visiting parks, intense UV irradiation similar to that of southern Europe was recorded.

–      In countries for which a high proportion of the population take holidays abroad, possibly being exposed to high levels of UV, prevention messages could be developed in partnership with travel agencies. This was a success in Denmark from the Danish Cancer Institute; during the traditional period of foreign holiday travels, specific advertisements for UV prevention were displayed on the media (flyers, websites, etc.) of travel agencies.

–      Despite foreign holidays for the French and Italians being relatively low, southern European countries tend to receive a large number of tourists from their northern counterparts. These tourists often have fair skin and a willingness to spend time outdoors, but for these individuals, no (or at best, limited) prevention messages are available in southern European countries. We believe that sun exposure prevention messages could be developed in southern European countries during the holiday period to target the northern European population.

EuroSun Partners

The EuroSun project, titled “Quantification of sun exposure in Europe and its effects on health” is an EU funded project (grant n.20065320). This project was financed for the period 2007-2011. This website presents the main results of this project. It will be regularly updated to include future development.

This project involves four teams from European institutes: iPRI, Lyon; INSERM, Lyon; ARMINES, Paris; and Karolinska Institutet, Stockholm.

The International Prevention Research Institute (iPRI) is an independent research institute founded and chaired by Prof.Peter Boyle. iPRI’s mission is to develop various activities aimed at improving the health of populations worldwide, identifying the main problems of detection and disease prevention.

The research of iPRI is mainly focused on the prevention of chronic disease. This work is carried out in collaboration with international partners. A priority of the Institute is to train researchers from low- and medium-resource countries.

iPRI is involved in many international projects of academic research, such as BBMRI, EuroSun and the European Code against Cancer.

Within iPRI, Dr. Mathieu Boniol is biostatistician; devoting his time particularly to the epidemiology of melanoma. He also participates in projects involving various meta-analyses (risk of melanoma, artificial light and skin cancer, vitamin D and cancer). He is also President Elect of EUROSKIN (European Society for Skin Cancer Prevention).

The National Institute of Health and Medical Research (Inserm)  is a French public organisation dedicated to medical research, under the joint supervision of the Ministry of Research and Ministry of Health. Inserm, the only French public research body entirely dedicated to human health, has been awarded, in 2008, responsibility for coordinating strategic, scientific and operational leadership in biomedical research. Its mission of coordination has led to the creation of 10 thematic institutes associated with Inserm, in early 2008.

Dr. Jean-François Doré is Emeritus Research Director at INSERM, Unit 590 “Oncogenesis and Tumor Progression” and specialises in the prevention of skin cancer and the extent of exposure to UV radiation. Dr. Doré is currently Chairman of EUROSKIN (European Society for Skin Cancer Prevention).

ARMINES is a contract research organisation where over 90% of the workforce is located in research centres. It manages the activities of the Research “Ecole des mines” in Paris (Mines ParisTech).

The concept of research “orientated” towards the industry is at the base of the creation of ARMINES in 1967. This type of research is based on an exchange between scientists and the industry, it´s neither pure research nor competitive but joint research. Its function is to contribute to the improvement of the technological standard and to the scientists’ progression in their fields of expertise. It´s also the motor for an education by research with, as a consequence, an important annual fluctuation of young scientists turning towards the industry, essential vector of the “transfer” of knowledge and know-how.

ARMINES aims to pool resources to answer questions posed by the economic and social sphere through its realisations to academic missions, research, school training and education.

Within ARMINES, Prof.Lucien Wald is responsible for the group Remote Sensing & Modelling, Center for Energy and Processes, since its founding in 1991. He has supervised doctoral students since 1981 and participates in teaching at the Ecole des Mines de Paris and the University. His activities are generally carried out in French, European or international consortiums.

Karolinska Institutet is one of the world´s leading medical universities, accounts for over 40% of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences. The university was founded in 1810 by King Karl XIII as an “academy for the training of skilled army surgeons”. Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine. With a close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and education.

Within Karolinska Institutet, Prof. Ulrik Ringborg has been conducting research in Oncology since 1992 in the Department of Oncology-Pathology. He has published more than two hundred articles in peer-reviewed journals, nearly half of them on skin cancer in various fields of research including epidemiology and biology, with subject matters ranging from primary prevention to treatment of cutaneous melanomas.

Dr. Asbjørn Følling
Latest posts by Dr. Asbjørn Følling (see all)
Legg igjen en kommentar

Din e-postadresse vil ikke bli publisert. Obligatoriske felt er merket med *

Offisiell leverandør

av medisinske produkter i Norge

Behov for Hjelp?

Kontakt oss her

Rask Levering

5-9 dager (Sporbar budtjeneste)

100% Sikker Utsjekking

MasterCard / Visa

© AS 2020. Jernbanetorget 6, 0154 Oslo, Norge